NCT03789318 - Study in Subjects Undergoing Complete Abdominoplasty | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

May 16, 2019

Study Completion Date

June 12, 2019

Conditions

Postsurgical Pain

Interventions

DRUG

CA-008 5 mg

5 mg CA-008 reconstituted in saline.

DRUG

Placebo

Each cohort will use placebo reconstituted in saline.

DRUG

Bupivacaine Hydrochloride

0.25% administered pre-surgery

DRUG

Hydromorphone

0.02 mg/kg IV administered intraoperatively

DRUG

Fentanyl

100 mcg IV administered intraoperatively

DRUG

Acetaminophen

1000 mg IV administered intraoperatively

DRUG

Oxycodone

5-10 mg PO administered post-surgery

DRUG

CA-008 10 mg

10 mg CA-008 reconstituted in saline.

DRUG

CA-008 15 mg

15 mg CA-008 reconstituted in saline.

Trial Locations (1)

Lotus Clinical Research, LLC, Pasadena